The Acquired Hemophilia Surveillance (AHS) Project: A Novel Mechanism of Capturing Post-Marketing Safety Information on rFVIIa (NovoSeven®RT) In Acquired Hemophilia

被引：0

|

作者：

Lentz, Steven R. ^{[1
]}

Tandra, Anand ^{[2
]}

Peters, Tracy J. ^{[1
]}

Cooper, David L. ^{[3
]}

机构：

[1] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA

[2] Hematol Indiana Hemophilia & Thrombosis Ctr, Indianapolis, IN USA

[3] Novo Nordisk Inc, Clin Med & Regulatory Affairs, Princeton, NJ USA

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1508 / 1508

页数：1

相关论文

共 14 条

[11] Post-Marketing Safety and Efficacy Evaluation of a Novel Drug CSE-1034: A Drug-Use Analysis in Paediatric Patients with Hospital- Acquired Pneumonia
Chaudhary, Manu
Ayub, Shiekh Gazalla
Mir, Mohd Amin
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (09) : OC25 - OC28
[12] Comparison of Prospective and Retrospective Methods of a Tigecycline Post-Marketing Surveillance Study in the Safety Outcomes of Patients with Complicated Skin Structure Infection, Complicated Intraabdominal Infection and Community-Acquired Pneumonia
Whanhui Chi
Hye Jung Lee
Yong Pil Chong
Infectious Diseases and Therapy, 2021, 10 : 411 - 420
[13] Comparison of Prospective and Retrospective Methods of a Tigecycline Post-Marketing Surveillance Study in the Safety Outcomes of Patients with Complicated Skin Structure Infection, Complicated Intraabdominal Infection and Community-Acquired Pneumonia
Chi, Whanhui
Lee, Hye Jung
Chong, Yong Pil
INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 411 - 420
[14] A post-marketing surveillance study of the safety and efficiacy of ReFacto® (Moroctocog Alfa, B-Domain deleted recombinant factor VIII) St. Louis-derived active substance in the treatment and prevension of bleeding episodes in hemophilia A patients.
Feingold, JM
Smith, MP
Littlewood, R
Giangrande, P
BLOOD, 2004, 104 (11) : 847A - 848A